Lenstec Receives FDA Clearance to Begin Clinical Trial of Softec HD IOL
13th Nov 2006, 19:52 GMT
AAO Annual Meeting -- Lenstec, Inc. -- a provider of technologically advanced lens implants and devices used in cataract and refractive surgery -- today announced that the U.S. Food and Drug Administration...
Lenstec Receives FDA Clearance to Begin Clinical Trial of Softec HD IOL related news:
- Lenstec, Inc.: Lenstec Receives FDA Clearance to Begin Clinical Trial of Softec HD IOL — Market Wire - Medical and Healthcare
- North American Scientific Announces FDA Clearance of its ClearPath HDR Breast Brachytherapy System — FDA News News from StratCenter.com
- ReGen Biologics Announces Results of FDA Appeal — Government/ Industry Regulation News from StratCenter.com
- Jurors Could Begin Deliberations In Allen Trial — NBC 17 - Local News
- Scientists Design A PSA-activated Protoxin That Kills Prostate Cancer: Phase I Clinical Trial Is Under Way — Health News from Medical News Today
- Study Findings Challenge Current Clinical Practice Clinical Trial Results Find Late Angioplasty after Heart Attack Offers No Advantage Over Standard Drug Therapy — National Institutes of Health (NIH) News Releases
- VIASYS NeuroCare Inc. Receives 510(K) Clearance for SONARA and SONARA/tek Digital Transcranial Doppler Systems — Nachrichten Ticker - www.finanzen.net
- New Treatment for Ischemic Stroke on the Horizon — Medscape Headlines
- ZymoGenetics and Serono Report Detailed Positive Results From Atacicept Phase 1b Clinical Trial in Patients With Lupus — PR Newswire: All Releases
- Human Genome Sciences Announces Positive 76-Week Results of Phase 2 Clinical Trial of LymphoStat-B(TM) in Systemic Lupus Erythematosus — PR Newswire: All Releases
Latest news from ArriveNet : Health:
- Gold Reserve announces improved Brisas Project economics and updates Brisas Project 43-101 Report
- PuriCore Plc announces Appointment
- Lisa Zuckerman Joins Catholic Healthcare West as Vice President of Treasury Services
- ORLive Presents: Minimally Invasive Aortic Valve Replacement Surgery -- Increasingly Popular Procedure to Correct Heart Function
- Adult Stem Cells Have Ability to Develop and Replicate Like Embryonic Stem Cells
- Extraordinary general meeting of Precise Biometrics AB approves of new share issue with preferential rights for shareholders of approximately SEK 85 million
- Invitation Conference Call Analyst Meeting
- IBEX: Analysis of Urinary C2C Distinguishes Between Individuals with Painful Knees and Individuals Identified by MRI to Have Early Osteoarthritis
- YES Secures 100 Country Distribution Deal, Announces First Int'l Shipments Begin
- Study to Be Published in JAMA: Diabetes Drug ACTOS(R) (pioglitazone HCl) Halted Progression of Key Marker for Atherosclerosis; Improvements Indicated by Carotid Intima-Media Thickness (CIMT)